PC
PLSE icon

Panoramic Capital’s Pulse Biosciences PLSE Stock Holding History

Panoramic Capital’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Buy
98,054
+40,000
+69% +$944K 1.17% 24
2026
Q1 		$1.25M Buy
58,054
+20,000
+53% +$369K 0.88% 31
2025
Q4 		$522K Buy
38,054
+2,058
+6% +$32.1K 0.28% 37
2025
Q3 		$637K Buy
35,996
+9,635
+37% +$152K 0.29% 45
2025
Q2 		$398K Sell
26,361
-26,362
-50% -$437K 0.3% 36
2025
Q1 		$848K Buy
52,723
+4,152
+9% +$77.4K 0.98% 25
2024
Q4 		$846K Buy
+48,571
New +$856K 0.45% 38

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Panoramic Capital's PLSE Position: Q2 2026 in Review

Panoramic Capital increased its Pulse Biosciences (PLSE) stake by 69% in Q2 2026, buying an estimated $944K and bringing the position to 98,054 shares worth $2.72M. The position accounts for 1.17% of the portfolio, ranked #24.

Panoramic Capital first reported a position in PLSE in Q4 2024 and has held it in 7 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Panoramic Capital held 98,054 shares of Pulse Biosciences worth $2.72M as of Q2 2026.
  • Panoramic Capital bought 40,000 Pulse Biosciences shares in Q2 2026, an estimated $944K.
  • Pulse Biosciences made up 1.17% of Panoramic Capital's portfolio in Q2 2026, its #24 holding.
  • Panoramic Capital first reported a position in Pulse Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Panoramic Capital's 13F filing for Q2 2026, filed 14 Aug 2026.